| Oral presentation schedule for October 23 (Thu), Day 1 |
| |
|
Kobe International Exhibition Hall No.2 Building |
Portopia Hotel |
Kobe International Conference Center |
Kobe International Exhibition Hall No.1 Building |
Kobe International Exhibition Hall No.3 Building |
Portopia Hotel |
|
| |
|
Hall (North) |
Hall (South) |
Conference
Room 3A |
Portopia Hall |
Ohwada A |
Ohwada B |
Ohwada C |
Kairaku 1+2 |
Kairaku 3 |
Waraku |
Topaz |
Main Hall |
International Conference Room |
Digital Poster Session & Commercial Exhibition |
Digital Poster Session & Commercial Exhibition |
Emerald |
|
| |
|
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
Room 8 |
Room 9 |
Room 10 |
Room 11 |
Room 12 |
Room 13 |
Room 14 |
Room 15 |
Room 16 |
|
| 8:00 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8:00 |
| 40 |
|
No planned seminars |
No planned seminars |
Breakfast
Seminar1 Astellas Pharma Inc./ Pfizer Japan Inc.
Basic Science and Evidence in Clinical Research of NSAID- associated GI Injuries |
|
No planned seminars |
Breakfast
Seminar2 AJINOMOTO PHARMA CEUTICALS CO., LTD.
Progress in treatment of Chronic pancreatitis and New Guideline |
Breakfast
Seminar3 Century Medical Inc.
Radio Frequency Ablation
–state-of-the-art technique– |
No planned seminars |
No planned seminars |
No planned seminars |
No planned seminars |
No planned seminars |
Breakfast
Seminar4 DAIICHI SANKYO CO., LTD./ Toray Industries, Inc.
New treatments and the future role of interferon-based therapy for hepatitis C |
|
|
|
40 |
| 45 |
Opening Ceremony |
45 |
| 50 |
|
|
|
|
|
|
|
|
|
|
|
|
50 |
| 9:00 |
|
9:00 |
| 40 |
|
S1 (JSH/JSGE)
Therapeutic strategies for prophylaxis and control of hepatitis B virus related hapatocellulrar carcinoma Chair: O. Yokosuka
H. Yatsuhashi |
S2 (JSGE/JGES/
JSGS)
What is an optimal treatment in initial stage of severe acute pancreatitis? Chair: T. Shimosegawa
Y. Takeyama |
W1 (JSGE/JGES/
JSGS)
Towards preservation and regeneration of defense mechanism in intestinal mucosa Chair: K. Fujimoto
H. Imaeda |
PD3 (JSGE/JGES)
GERD - Emerging problems in its research and clinical practice (controversies in GERD and its complications) Chair: H. Goto
Y. Kinoshita |
Invited Lecture (Keynote Lecture) (JSH)
Stemness and reprogramming in liver cancer S. S. Thorgeirsson
Chair: G. Shiota
I. Sakaida |
Invited Lecture (Keynote Lecture) (JSGE)
New perspectives in functional dyspepsia J. Tack
Chair: H. Suzuki |
S4 (JSH/JSGE)
Pathologic analysis and new therapeutic options for NAFLD/NASH Chair: S. Watanabe
T. Saibara |
S5 (JSGCS/JSGE/
JGES)
How should the Helicobacter pylori induced gastritis be managed in the gastric cancer screening? Chair: D. Shibuya
T. Ambo |
Live broadcast Room 1 |
Live broadcast Room 2 |
Live broadcast Room 3 |
PD5 (JSGE)
Gastrointestinal tract and cancer stem cells Chair: T. Joh
T. Azuma |
S7 (JSH/JSGE/
JSGS)
The biomarker investigation in patients with hepatocellular carcinoma for future clinical practice Chair: E. Miyoshi
M. Sakamoto |
| Commercial Exhibition |
| Commercial Exhibition |
Gastrointestinal and Pancreaticobiliary Endoscopy Live Seminar (JGES) |
40 |
| 45 |
IS-S3 (JSGE)
Functional dyspepsia and its new perspective Chair: H. Miwa
H. Suzuki |
45 |
| 10:00 |
IS-S1 (JSH/JSGE/
JSGS)
Stem cells in liver regeneration and therapy: Present and future scope Chair: G. Shiota
I. Sakaida |
10:00 |
| 11:00 |
|
|
|
11:00 |
| 20 |
|
|
|
20 |
| 30 |
Special Lecture (JSGE)
Grand challenge in life science on Supercomputer K R. Himeno
Chair: S. Miura |
30 |
| 12:00 |
Lecture by Congress President (JSGCS)
Gastrointestinal cancer screening in the near future K. Inoue
Chair: A. Fukao |
12:00 |
| 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
| 13:00 |
Academic Council (Japanese Society of Gastroenterology)
12:30-13:40 |
Luncheon
Seminar28 Bristol-Myers Squibb
The 5th Bristol–Myers Award Ceremony
The final stage of hepatitis C treatment
–The treatment strategy with a new interferon-free oral dual regimen– |
Luncheon
Seminar29 HOYA Corporation
The New Prospect of ESD with OE |
No planned seminars |
Luncheon
Seminar30 MSD K.K.
The 13th MSD Award Ceremony
Newly triple therapy for chronic hepatitis C |
Luncheon
Seminar31 Astellas Pharma Inc./ ZERIA Pharmaceutical Co., Ltd.
Pathophysiology and management of functional dyspepsia
–Introduction of FD guideline and key points of pharmacological treatment– |
Luncheon
Seminar32 Sysmex Corporation
The development strategy of glycobiomarkers for accurate disease assessment
–A case of hepatic fibrosis marker– |
Luncheon
Seminar33 Otsuka Pharmaceutical Co., Ltd.
Population-based screening of gastric cancer in Helicobacter pylori era. – A new framework of gastric cancer screening focusing on high-risk population and follow-ups after eradication.– |
Luncheon
Seminar34 Bayer Yakuhin, Ltd.
Diagnosis and Treatment of HCC：UP-TO-DATE |
Luncheon
Seminar35 Eisai Co., Ltd.
|
Luncheon
Seminar36 NIPPON SHINYAKU CO., LTD
Alcohol-related organ damage and effect of abstinence |
Luncheon
Seminar37 JIMRO Co., Ltd.
Optimization of GMA therapy in patients with IBD |
Luncheon
Seminar38 AJINOMOTO PHARMA CEUTICALS CO., LTD.
The16th AJINOMOTO Award Ceremony
Diabetes and liver cancer: tips in clinical practice |
13:00 |
| 40 |
|
|
|
|
40 |
| 14:00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
14:00 |
| 30 |
|
PD1 (JSH/JSGE)
New trends and goal of hepatitis C therapy Chair: N. Izumi
K. Chayama |
PD2 (JSGE/JGES/
JSGS)
Gastrointestinal bleeding and effective measures against it in the elderly Chair: C. Sakamoto
I. Hirata |
Invited Lecture (JSGCS)
Results of a colorectal cancer screening program in Brazil C. R. Teixeira
Chair: K. Haruma |
S3 (JSGE/JGES/
JSGS)
Intractable Crohn's disease: Therapeutic approaches based on its pathophysiology Chair: Y. Kohgo
M. Watanabe |
Invited Lecture (Keynote Lecture) (JSH)
Progress and challenges in hepatic fibrosis S. L. Friedman
Chair: N. Kawada
H. Yoshiji |
L-IS1 (JSGE)
International panel discussion with Asian Pacific GI leaders 'Current clinical trend and future of GI disorders in Asian-Pacific region' K. M. Fock
K.-L. Goh
Y.-Q. Li
J.-T. Lin
U. Kachintorn
J.-G. Kim
M. Simadibrata
S. P. Singh
Chair: K. Sugano
K.-L. Goh |
PD4 (JSH/JSGE/
JGES/JSGS)
Pathologic analysis and treatment options of autoimmune hepato-biliary diseases Chair: M. Zeniya
H. Ohira |
S6 (JSGCS/JSGE/
JGES)
The present situation and problem of risk assessment for gastric cancer Chair: M. Yoshihara
T. Kamada |
Live broadcast Room 1 |
Live broadcast Room 2 |
Live broadcast Room 3 |
Special Lecture (JSGE)
Impact of immunogenomics and immunopharmacogenomics in medical science in the 21st century Y. Nakamura
Chair: K. Yamamoto |
W3 (JSH/JSGE/
JSGS)
Acute liver failure: Future prospects of novel treatment options for better prognosis Chair: S. Mochida
A. Ido |
Digital Poster Session
(JSGE)
14:00-16:30 |
|
Digital Poster Session
(JSH)
14:00-16:30 |
|
Gastrointestinal and Pancreaticobiliary Endoscopy Live Seminar (JGES) |
30 |
| 45 |
W2 (JSGCS/JSGE/
JGES)
Evaluation of CT colonography as diagnostic examination in
colorectal cancer screening Chair: R. Nozaki
T. Shimada |
45 |
| 15:00 |
IS-S2 (JSH/JSGE)
Mechanisms of hepatic and pancreatic fibrosis ; Clinical implications Chair: N. Kawada
H. Yoshiji |
PD6 (JSGE/JSGS)
Novel therapeutic strategy for pancreatic and bile duct cancer based on molecular targeting and anti-tumor immunity Chair: K. Yamamoto
H. Ohnishi |
15:00 |
| 16:00 |
|
16:00 |
| 30 |
|
30 |
| 17:00 |
|
|
17:00 |
| 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
| 18:00 |
No planned seminars |
No planned seminars |
Satellite
Symposium72 TAIHO PHARMACEUTICAL CO. LTD
Esophageal Function and GERD Treatment in Japanese Patients |
No planned seminars |
Satellite
Symposium73 Janssen Pharmaceutical K.K.
|
Satellite
Symposium74 Sumitomo Dainippon Pharma Co., Ltd.
Treatment strategy of the chronic liver disease –Unsolved problem in hepatitis treatment– |
Satellite
Symposium75 FUJIFILM Medical Co., Ltd.
Novel Evolution of Trans-nasal Endoscopy |
Satellite
Symposium76 MSD K.K.
Expanding the possibility of IFN containing therapy |
Satellite
Symposium77 Wako Pure Chemical Industries, Ltd.
The role of Gastric cancer risk classification (ABC classification) in the era of primary gastric cancer prevention |
Satellite
Symposium78 KYORIN PHARMACEUTICAL CO., LTD
How do you maximize the value of PENATSA family? |
Satellite
Symposium79 EIKEN CHEMICAL CO., LTD.
Colorectal Cancer Screening Now and Future
–To Reduce The Mortality of Colorectal Cancer |
Satellite
Symposium80 ZERIA Pharmaceutical Co., Ltd./ Kyowa Hakko Kirin Co., Ltd.
Verification of endoscopic indices and definition of mucosal healing in ulcerative colitis –Focus on in-depth discussion between domestic and international IBD experts– |
Western District Council (Japan Society of Hepatology)
17:30-18:30 |
18:00 |
| 30 |
|
|
|
|
30 |
| 40 |
|
|
|
40 |
| 19:00 |
|
19:00 |
| 30 |
|
|
|
|
|
|
|
|
|
|
|
30 |
| 20:00 |
|
|
|
|
|
|
20:00 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
